FDA Inspection
Graviti Pharmaceuticals Private LimitedGraviti Pharmaceuticals Private Limited – FDA Inspection, Feb 3, 2023
Record Details
This FDA Inspection record concerns Graviti Pharmaceuticals Private Limited, with an inspection on February 3, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0b0764cc-8d17-41f5-83bc-f3c6819f59e8
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1199883
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Graviti Pharmaceuticals Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 28, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| April 13, 2018 | Not classified | Office of Inspections and Investigations | |
| August 4, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Graviti Pharmaceuticals Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.